HIVNews Articles
WHO Urges Action Against HIV Drug Resistance Threat
Geneva -??WHO alerts countries to the increasing trend of resistance to HIV drugs detailed in a report based on national surveys conducted in several countries. The Organization warns that this
HecolinInnovaxNews Articles
A Giant Step Forward, INNOVAX’s Hecolin® Is Expected to Enter the Pakistani Market Early 2018!
Drug Regulatory Authority of Pakistan announced the approval of Hepatitis E vaccine, Hecolin? as per import policy for finished drugs and valid legalized COPP on July 15 this year. Dr. Huma
InnovaxNews Articles
PATH & Innovax Enter Collaboration to Accelerate HPV2 Supply in Developing Countries
On 30th June, 2017, PATH and Xiamen Innovax Biotech Co., Ltd (Innovax) finalized the Collaboration and Global Access agreement under which PATH will provide technical assistance to support
HIVNews Articles
Kenyans Are First in Africa to Get Generic of Latest AIDS Drug
Nairobi (Thomson Reuters Foundation) – Kenya is the first African country to start using a generic version of the latest AIDS drug that can improve and prolong the lives of tens of
EV-71Scientific Articles
Enterovirus 71 Inhibits Pyroptosis Through Cleavage of Gasdermin D
Abstract – Enterovirus 71 (EV71) can cause hand-foot-and-mouth disease (HFMD) in young children. Severe infection with EV71 can lead to neurological complications and even death. However,
HecolinInnovaxNews Articles
Collaboration with Icddr,b, the First International Show of the HEV Vaccine – Hecolin®
Since 2016, Innovax have been cooperating with International Centre for Diarrhoeal Disease Research, Bangladesh(icddr,b) scientists to conduct research on a vaccine for Hepatitis E, a troubling
News ArticlesTuberculosis
Drug-Resistant TB on the Rise in These Four Countries
Cases of multidrug-resistant and extensively drug-resistant tuberculosis are expected to increase in four countries with a high burden of multidrug-resistant tuberculosis from 2000 to 2040,